US Broker Ratings

Corcept Therapeutics (CORT): Investor Outlook Reveals a Promising 21% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a notable player in the biotechnology sector, focusing on the development of therapies for severe endocrinologic, oncologic, metabolic, and neurologic disorders. As of now,..

Royalty Pharma (RPRX) Stock Analysis: Is the 6.05% Potential Upside Worth the Investment?

Royalty Pharma plc (NASDAQ: RPRX) is capturing the attention of investors with its unique business model and promising financial indicators. As a trailblazer in the biopharmaceutical royalty acquisition space, Royalty..

Solventum Corporation (SOLV) Rating Update: Navigating the Healthcare Landscape with Strong ROE and Potential Upside

Solventum Corporation (NYSE: SOLV), a notable player in the healthcare sector, is making strides with its innovative solutions across Medsurg, Dental Solutions, and Health Information Systems. With a market capitalization..

Charles River Laboratories (CRL) Stock Analysis: Unpacking the 17% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $8.73 billion,..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Healthcare Distribution with a 12.61% Upside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, stands as a key player in the medical distribution industry. With a market capitalization of $8.82 billion, the company..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 39.68% Potential Upside in Biotech Innovation

Investors with an eye on the biotechnology sector might find Sarepta Therapeutics, Inc. (NASDAQ: SRPT) an intriguing prospect, given its potential upside of nearly 39.68%. As a key player in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Decoding the Growth Potential in Healthcare Research

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specializes in diagnostics and research services, offering a comprehensive suite of clinical development services for the pharmaceutical, biotechnology,..

Medtronic plc (MDT) Investor Outlook: A 20.7% Potential Upside Beckons for This Medical Device Giant

Medtronic plc (NYSE: MDT), a heavyweight in the medical devices industry, is capturing investor attention with a compelling potential upside of 20.7%, based on its average target price. This Dublin-headquartered..

Bruker Corporation (BRKR) Stock Analysis: Navigating the Healthcare Sector with a 2.70% Revenue Growth

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a multifaceted investment case. With a market capitalization of $8.58 billion, Bruker is a..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Unveiling a 111.86% Potential Upside in the Biotech Arena

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing the attention of investors with its bold ambitions in the biotechnology sector, particularly in the niche of RNA therapeutics aimed at cardiomyopathies. The..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 52.60% Revenue Growth in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with an impressive 52.60% revenue growth, a figure that stands out in a market often characterized by..

Zoetis Inc. (ZTS) Stock Report: Analyzing the Animal Health Leader’s 56.83% Potential Upside

For investors eyeing robust opportunities within the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents a compelling case. With a market capitalization of $33.3 billion, Zoetis stands as a leader in..

RadNet, Inc. (RDNT) Stock Analysis: Strong Buy Ratings Signal a Promising 65% Upside Potential

Investors eyeing the healthcare sector should pay close attention to RadNet, Inc. (NASDAQ: RDNT), a prominent player in the diagnostics and research industry. With a market capitalization of $4.27 billion..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 19.52% Upside Potential in Biotechnology

Investors looking for opportunities within the biotechnology sector may find TG Therapeutics, Inc. (NASDAQ: TGTX) an intriguing prospect. As a commercial-stage biopharmaceutical company, TG Therapeutics is carving a niche in..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 22.15% Potential Upside in the Healthcare Information Sector

In the dynamic landscape of healthcare information services, Doximity, Inc. (NYSE: DOCS) presents an intriguing opportunity with a notable potential upside of 22.15%. As a prominent player in the digital..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 41.52% Potential Upside in the Medical Instruments Sector

AptarGroup, Inc. (NYSE: ATR) stands as a notable player within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Crystal Lake, Illinois, AptarGroup is renowned for..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Compelling Healthcare Play with 8% Upside Potential

BrightSpring Health Services, Inc. (NYSE: BTSG) is garnering attention in the healthcare sector, particularly within the health information services industry. With a robust $11.32 billion market capitalization, BrightSpring operates a..

Bristol-Myers Squibb (BMY) Investor Outlook: Analyzing a Promising 10.14% Upside and 4.40% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) stands as a towering figure in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $116.95 billion, this biopharmaceutical giant..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking the 76.56% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors within the healthcare sector, particularly those focused on biotechnology. The company, headquartered in Somerset, New Jersey, is making significant..

Alkermes plc (ALKS) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is attracting significant attention from investors, thanks to its robust revenue growth and strong analyst ratings. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds